I’m looking for education in
Clinical Topic
Webcast
1.50 CME
Drilling Down on Interleukin-33
Webcast
1.50 CME
New Avenues in Hypertension
Webcast
1.50 AMA PRA
Epithelial Cytokines in the Spotlight
Webcast
1.50 CME
Eosinophilic Esophagitis in the Spotlight
Webcast
1.00 CME
CA Part 2: CAR T-Cell Therapy in NHL Subtypes
Webcast
1.00 CME
FL Part 2 - CAR T-cell Therapy in NHL Subtypes
Webcast Series
1.00
AMA PRA
Calling the Shots
Webcast
0.75 CME/CE
ACTIVATE PrEP
Webcast
1.50 CME
Drilling Down on Interleukin-33
New Treatment Avenues for COPD and Acute Respiratory Infections
| Faculty: | Professor Tom Wilkinson, MA Cantab, MBBS, PhD, FRCP, FERS; Professor James Dodd, MBCHB, MRCP, PhD |
| Release: | 10/20/2026 |
| Expiration: | 11/20/2026 |
Webcast
1.50 CME
New Avenues in Hypertension
Evolving Management of Uncontrolled and Resistant Disease
| Faculty: | John M. Flack, MD, MPH; Karol Watson, MD, PhD ; Kausik Umanath, MD, MS, FACP, FASN |
| Release: | 10/20/2026 |
| Expiration: | 11/21/2026 |
Webcast
1.50 AMA PRA
Epithelial Cytokines in the Spotlight
Focusing on Chronic Rhinosinusitis With Nasal Polyps
| Faculty: | Joseph K. Han, MD, FARS, FAAOA; Rohit K. Katial, MD; Stella Lee, MD |
| Release: | 10/18/2026 |
| Expiration: | 11/18/2026 |
Webcast
1.50 CME
Eosinophilic Esophagitis in the Spotlight
Epithelial Cytokines from Disease Pathogenesis to Biologic Treatment
| Faculty: | Maureen Bauer, MD; Evan Dellon, MD, MPH; Girish Hiremath, MD, MPH |
| Release: | 10/10/2026 |
| Expiration: | 11/10/2026 |
Webcast
1.00 CME
CA Part 2: CAR T-Cell Therapy in NHL Subtypes
A Case-Based Workshop
| Faculty: | Ayad Hamdan, MD |
| Release: | 10/08/2026 |
| Expiration: | 11/12/2026 |
Webcast
1.00 CME
FL Part 2 - CAR T-cell Therapy in NHL Subtypes
A Case-Based Workshop
| Faculty: | Frederick Locke, MD |
| Release: | 09/23/2026 |
| Expiration: | 10/28/2026 |
Webcast Series
1.00 AMA PRA
Calling the Shots
| Course 1: | Immunotherapy for Older Adults With Metastatic cSCC |
| Course 2: | Anticipating and Managing Immune-Related Adverse Events |
| Course 3: | Defining High Risk and the Role of Adjuvant Immunotherapy |
| Course 4: | Individualizing Immunotherapy for Metastatic cSCC |
Webcast
0.75 CME/CE
ACTIVATE PrEP
Adopting Clinic Transformation for Immediate, Viable, and Timely Execution
| Faculty: | Stacey B. Trooskin, MD, PhD, MPH |
| Release: | 08/28/2026 |
| Expiration: | 08/28/2027 |
